2.67MMarket Cap-295P/E (TTM)
1.3500High1.1100Low272.56KVolume1.1500Open1.1700Pre Close335.10KTurnover15.76%Turnover RatioLossP/E (Static)2.36MShares4.300052wk High0.42P/B1.95MFloat Cap0.600052wk Low--Dividend TTM1.73MShs Float290.0000Historical High--Div YieldTTM20.51%Amplitude0.6000Historical Low1.2290Avg Price1Lot Size
Virax Biolabs Stock Forum
Shares of nano-cap diagnostics company Virax Biolabs Group (NASDAQ:VRAX) more than doubled in value in the morning hours Thursday as the company drew Wall Street's attention amid a rising number of bird flu cases worldwide.
Several countries, including the U.S., have already reported human bird flu infections as the highly pathogenic avian influenza virus, including its H5N1 form, continues to spread in poultry and cattle.
No comment yet